NMDA receptor encephalitis with cancer of unknown primary origin

Tumori. 2016 Nov 11;102(Suppl. 2). doi: 10.5301/tj.5000447.

Abstract

Purpose: N-methyl-D-aspartate receptor (NMDAR) encephalitis may present as a paraneoplastic syndrome in young women and is often associated with ovarian teratoma.

Methods: We report 2 male cases of NMDAR encephalitis presenting with metastatic cancer of unknown primary origin.

Results: Both patients showed cognitive dysfunction as well as other neurological symptoms, slow waves on EEG, and NMDAR antibodies in sera and CSF. Symptoms were effectively treated by pulse steroid and intravenous immunoglobulin treatment. The patients developed metastatic small cell neuroendocrine carcinoma of the parotid gland and inguinal metastatic squamous cell cancer shortly after their neurological episodes. Follow-up PET studies showed small cell lung cancer in the first patient while no primary origin could be found in the second patient.

Conlusions: Our cases imply that NMDAR encephalitis may present with metastatic cancers that display slow progression rates and occur after encephalitis attacks.

Publication types

  • Case Reports

MeSH terms

  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis / diagnosis*
  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis / drug therapy
  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis / surgery
  • Autoantibodies / cerebrospinal fluid
  • Biopsy
  • Combined Modality Therapy
  • Diagnostic Imaging
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Neoplasms, Unknown Primary / diagnosis*
  • Neoplasms, Unknown Primary / drug therapy
  • Neoplasms, Unknown Primary / surgery
  • Small Cell Lung Carcinoma / pathology
  • Treatment Outcome

Substances

  • Autoantibodies